Competitive collaboration in the pharmaceutical and biotechnology industry

被引：14
作者：
Bingham, Alph [1 ,2 ,3 ]
Ekins, Sean [4 ,5 ,6 ,7 ]
机构：
[1] Cascade Consulting, Carmel, IN 46033 USA
[2] InnoCentive Inc, Waltham, MA USA
[3] Monitor Talent, Cambridge, MA 02141 USA
[4] Collaborat Drug Discovery Inc, Burlingame, CA USA
[5] Collaborat Chem, Jenkintown, PA 19046 USA
[6] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21202 USA
[7] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
来源：
DRUG DISCOVERY TODAY | 2009年 / 14卷 / 23-24期
关键词：
DRUG DEVELOPMENT; INFORMATICS; DISCOVERY; MEDICINES;
D O I：
10.1016/j.drudis.2009.10.003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1079 / 1081
页数：3
相关论文
共 9 条
  • [1] Bangs A, 2005, ST HEAL T, V111, P37
  • [2] OPINION Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery
    Barnes, Michael R.
    Harland, Lee
    Foord, Steven M.
    Hall, Matthew D.
    Dix, Ian
    Thomas, Scott
    Williams-Jones, Bryn I.
    Brouwer, Cory R.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (09) : 701 - 708
  • [3] Risks in new drug development: Approval success rates for investigational drugs
    DiMasi, JA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (05) : 297 - 307
  • [4] The price of innovation: new estimates of drug development costs
    DiMasi, JA
    Hansen, RW
    Grabowski, HG
    [J]. JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) : 151 - 185
  • [5] Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development
    Ekins, Sean
    Williams, Antony J.
    [J]. LAB ON A CHIP, 2010, 10 (01) : 13 - 22
  • [6] FDA, 2004, INN STAGN CHALL OPP
  • [7] Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery
    Hohman, Moses
    Gregory, Kellan
    Chibale, Kelly
    Smith, Peter J.
    Ekins, Sean
    Bunin, Barry
    [J]. DRUG DISCOVERY TODAY, 2009, 14 (5-6) : 261 - 270
  • [8] The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients
    Hunter, A. Jackie
    [J]. DRUG DISCOVERY TODAY, 2008, 13 (9-10) : 371 - 373
  • [9] The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level
    Kamel, N.
    Compton, C.
    Middelveld, R.
    Higenbottam, T.
    Dahlen, S-E.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (05) : 924 - 926
1